Loading...
Sitagliptin/Simvastatin: a first combination tablet to treat type 2 diabetes and hypercholesterolemia – a review of its characteristics
BACKGROUND: The purpose of this study was to review the current literature and information on the combination product Juvisync™ (sitagliptin + simvastatin), which was approved by the US Food and Drug Administration in October 2011. METHODS: PubMed (2001–2014) was searched for primary and review arti...
Na minha lista:
| Udgivet i: | Vasc Health Risk Manag |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4334171/ https://ncbi.nlm.nih.gov/pubmed/25709467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S79198 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|